Clera home
·Dashboard

Jobs at Viking Therapeutics, Inc. (Now Hiring) — 5 open

Viking Therapeutics, Inc. logoViking Therapeutics, Inc.

Stability Coordinator/Manager

San Diego, California, United States · On-site

$100k–$125k/yr

Mid level$1.1B raised

Description The Stability Coordinator / Manager is responsible for planning, coordinating, and managing drug substance and drug product stability programs in support of Viking Therapeutics’ CMC pipeline. This role partne…

Skills: Stability Program Management, ICH Guidelines, cGMP Compliance, CMC Documentation, OOS/OOT Investigations

Viking Therapeutics, Inc. logoViking Therapeutics, Inc.

Quality System Specialist (Veeva eQMS Specialist)

San Diego, California, United States · On-site

$95k–$115k/yr

Mid level$1.1B raised

Description We are seeking an experienced Veeva eQMS Specialist with deep expertise in Veeva Basics, ideally someone who has led or played a key role in full implementations across QualityDocs, QMS, Training, and other V…

Skills: Veeva Vault, eQMS Implementation, QualityDocs, GxP, 21 CFR Part 11

Viking Therapeutics, Inc. logoViking Therapeutics, Inc.

Director, Quality Systems

San Diego, California, United States · On-site

$170k–$210k/yr

Senior+$1.1B raised

Description The Director Quality Systems will lead and support quality assurance and quality systems activities for Viking’s clinical and commercial-stage operations. The role advances the company's Quality Management Sy…

Skills: Quality Management Systems, GMP Compliance, FDA Regulations, Veeva eQMS, Quality Risk Management

Viking Therapeutics, Inc. logoViking Therapeutics, Inc.

Director/Senior Director, MSAT

San Diego, California, United States · On-site

$190k–$220k/yr

Senior+

Description The Director / Senior Director of Manufacturing Science and Technology (MSAT) provides leadership and technical governance across all manufacturing and validation activities executed within a global external …

Skills: MSAT Leadership, Process Validation, Technology Transfer, CDMO Management, Lifecycle Management

Viking Therapeutics, Inc. logoViking Therapeutics, Inc.

Drug Safety Associate

San Diego, California, United States · On-site

$77k–$90k/yr

Mid level

Description The Drug Safety Associate provides operational and documentation support for the company’s clinical safety and pharmacovigilance activities. Working closely with the Drug Safety Manager, this role helps ensur…

Skills: Pharmacovigilance, Clinical Research, Safety Case Tracking, TMF Filing, MedDRA

Viking Therapeutics, Inc. logo

Stability Coordinator/Manager

Viking Therapeutics, Inc.

San Diego, California, United States • On-site

Apply
Mid level

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $100k–$125k/yr
  • Full-time
  • bachelor degree, postgraduate degree
  • Posted 10d ago
  • ~40 hrs/week

Responsibilities

Plan and manage drug substance and drug product stability programs to support the CMC pipeline. Coordinate with internal teams and external CROs/CMOs to design ICH-compliant protocols and contribute stability data to regulatory filings.

Requirements

Requires a B.S. in Chemistry or related field with 4+ years of experience, or an M.S. with 2+ years, or a Ph.D. Candidates must have demonstrated experience in pharmaceutical stability program management and working knowledge of ICH and cGMP requirements.

Full job description

Description

The Stability Coordinator / Manager is responsible for planning, coordinating, and managing drug substance and drug product stability programs in support of Viking Therapeutics’ CMC pipeline. This role partners closely with internal Analytical Development, Drug Substance, Drug Product, Quality, and Regulatory Affairs teams, as well as with external contract research organizations (CROs), contract manufacturing organizations (CMOs), and contract testing laboratories, to plan and execute phase-appropriate stability studies from early-stage development through late-stage clinical and pre-commercial activities. The Stability Coordinator / Manager will design and oversee ICH-compliant stability protocols, manage sample inventory and pull schedules, trend and interpret stability data, and support shelf-life and expiry determinations for small molecule and peptide-based products. The role will contribute stability data and sections to CMC documentation and regulatory submissions across Viking’s portfolio, including the company’s lead GLP-1/GIP dual agonist programs (VK2735) and additional metabolic and endocrine disorder pipeline assets. The level of the role will be commensurate with the candidate’s experience and qualifications.

Essential Duties and Responsibilities

The main responsibilities of this role include:

  • Coordinate and manage drug substance and drug product stability programs under ICH storage conditions, including protocol design, sample pull schedules, and inventory across internal programs and outsourced testing laboratories.
  • Author, review, and maintain stability protocols, reports, specifications, and trend analyses; ensure phase-appropriate stability strategies aligned with each program’s development stage.
  • Track and trend stability data and lead or support out-of-specification (OOS) and out-of-trend (OOT) investigations in collaboration with Analytical Development and Quality.
  • Serve as the primary point of contact for external CROs, CMOs, and contract testing laboratories for stability activities; manage sample logistics, chamber storage, timelines, and data deliverables for outsourced testing.
  • Establish and justify shelf-life, retest, and expiry assignments based on stability data and applicable ICH guidelines.
  • Contribute stability data and sections to CMC portions of INDs, CTAs, NDAs, and other regulatory filings (3.2.S.7 / 3.2.P.8); support responses to agency questions in collaboration with Regulatory Affairs.
  • Maintain compliance with ICH stability guidelines (Q1A–Q1F, Q5C) and cGMP requirements; ensure sound GMP documentation practices and data integrity (ALCOA+).
  • Partner cross-functionally with Drug Product, Drug Substance, Analytical Development, Quality, Supply Chain, and Regulatory to ensure integrated, on-time stability deliverables.
  • Provide stability program updates at integrated project team meetings and present data trends, risks, and timelines to technical and executive stakeholders.
  • Other duties as assigned.

Requirements

Education and Experience

  • B.S. in Chemistry, Pharmaceutical Sciences, Biochemistry, or related discipline with 4+ years of relevant pharmaceutical/biotech experience in stability and/or analytical operations; or M.S. with 2+ years; or Ph.D. with relevant experience.
  • Title (Coordinator vs. Manager) will be commensurate with the candidate’s experience and qualifications.

Knowledge and Skills

  • Demonstrated hands-on experience managing pharmaceutical stability programs for drug substance and/or drug product, including ICH-compliant study design, execution, and data review.
  • Experience working with external CROs, CMOs, and contract testing laboratories; track record of managing outsourced stability testing to deliver on time and within budget.
  • Working knowledge of ICH stability guidelines (Q1A–Q1F, Q5C), cGMP requirements, and regulatory expectations for stability data in CMC submissions (3.2.S.7 / 3.2.P.8).
  • Experience with stability data trending, OOS/OOT investigations, shelf-life and expiry determination, and stability-indicating analytical methods.
  • Experience with peptide or GLP-1/GIP agonist product stability, degradation pathways, or cold-chain handling, and familiarity with stability data management systems / LIMS and data integrity (ALCOA+) practices, is a plus.
  • Strong written and verbal communication skills; ability to translate stability data into clear reports and regulatory documents, and to present effectively to cross-functional and executive stakeholders.
  • Entrepreneurial mindset with the ability to thrive in a fast-paced, lean biotech environment; strong organizational skills, attention to detail, and the ability to manage multiple priorities and sample/schedule logistics simultaneously.

VIKING THERAPEUTICS

Viking Therapeutics, Inc., is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Viking Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.

Notice to Agency and Search Firm Representatives

Viking Therapeutics, Inc. is not accepting unsolicited resumes from agencies and/or search firms for this job posting. Resumes submitted to any Viking employee by a third-party agency and/or search firm without a valid written & signed search agreement, and assignment of specific position, will become the sole property of Viking Therapeutics, Inc. No fee will be paid if a candidate is hired for this position as a result of an unsolicited agency or search firm referral.

Salary Description

$100,000.00 - $125,000.00 annual salary

Related keywords

Stability CoordinatorCMCICH Q1A-Q1FICH Q5CcGMPALCOA+LIMSINDCTANDAGLP-1/GIPPeptidesSmall MoleculeDrug SubstanceDrug ProductOOS

About Viking Therapeutics, Inc.

LinkedInVisit site
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Founded
2012
Headquarters
San Diego, California
LinkedIn followers
13,355
Total funding
$1.1B

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).

Offices: 9920 Pacific Heights Blvd,, Suite 350, San Diego, California 92121, US

Health CareMedicalTherapeutics
View all jobs at Viking Therapeutics, Inc.

About Viking Therapeutics, Inc.

LinkedInVisit site
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Founded
2012
Headquarters
San Diego, California
LinkedIn followers
13,355
Total funding
$1.1B

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).

Offices: 9920 Pacific Heights Blvd,, Suite 350, San Diego, California 92121, US

Health CareMedicalTherapeutics
View all jobs at Viking Therapeutics, Inc.

Similar companies hiring

Allergan (2213)Johnson & Johnson Innovative Medicine (1826)MSD (1344)Novartis (1316)AstraZeneca (1181)Takeda (1123)Sanofi (967)Grifols (935)PiSA Farmacéutica (798)Adelphi Group (720)Bristol Myers Squibb (655)Boehringer Ingelheim (622)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty